Introduction: Eye tracking provides a convenient and promising biological marker of cognitive impairment in patients with neurodegenerative disease. Here we report a longitudinal study of saccadic eye movements in a sample of patients with Alzheimer's disease and elderly control participants who were assessed at the start of the study and followed up 12-months later.Methods: Eye movements were measured in the standard gap and overlap paradigms, to examine the longitudinal trends in the ability to disengage attention from a visual target.Results: Overall patients with Alzheimer's disease had slower reaction times than the control group. However, after 12-months, both groups showed faster and comparable reductions in reaction times to the gap, compared to the overlap stimulus. Interestingly, there was a general improvement for both groups with more accurately directed saccades and speeding of reaction times after 12-months.Conclusions: These findings point to the value of longer-term studies and follow-up assessment to ascertain the effects of dementia on oculomotor control.
Research shows that self-control is resource limited and there is a gradual weakening in consecutive self-control task performance akin to muscle fatigue. A body of evidence suggests that the resource is glucose and consuming glucose reduces this effect. This study examined the effect of glucose on performance in the antisaccade task - which requires self-control through generating a voluntary eye movement away from a target - following self-control exertion in the Stroop task. The effects of motivation and individual differences in self-control were also explored. In a double-blind design, 67 young healthy adults received a 25g glucose or inert placebo drink. Glucose did not enhance antisaccade performance following self-control exertion in the Stroop task. Motivation however, predicted performance on the antisaccade task; more specifically high motivation ameliorated performance decrements observed after initial self-control exertion. In addition, individuals with high levels of self-control performed better on certain aspects of the antisaccade task after administration of a glucose drink. The results of this study suggest that the antisaccade task might be a powerful paradigm, which could be used as a more objective measure of self-control. Moreover, the results indicate that level of motivation and individual differences in self-control should be taken into account when investigating deficiencies in self-control following prior exertion.
Self-control is important for everyday life and involves behavioral regulation. Self-control requires effort, and when completing two successive self-control tasks, there is typically a temporary drop in performance in the second task. High self-reported motivation and being made self-aware somewhat counteract this effect-with the result that performance in the second task is enhanced. The current study explored the relationship between self-awareness and motivation on sequential self-control task performance. Before employing self-control in an antisaccade task, participants initially applied self-control in an incongruent Stroop task or completed a control task. After the Stroop task, participants unscrambled sentences that primed self-awareness (each started with the word "I") or unscrambled neutral sentences. Motivation was measured after the antisaccade task. Findings revealed that, after exerting selfcontrol in the incongruent Stroop task, motivation predicted erroneous responses in the antisaccade task for those that unscrambled neutral sentences, and high motivation led to fewer errors. Those primed with self-awareness were somewhat more motivated overall, but motivation did not significantly predict antisaccade performance. Supporting the resource allocation account, if one was motivated-intrinsically or via the manipulation of self-awarenessresources were allocated to both tasks leading to the successful completion of two sequential self-control tasks.
Research on malingering detection has not yet taken full advantage of eye tracking technology. In particular, while several studies indicate that patients with schizophrenia behave notably differently from controls on specific oculomotor tasks, no study has yet investigated whether experimental participants instructed to feign could reproduce those behaviors, if coached to do so. Due to the automatic nature of eye movements, we anticipated that eye tracking analyses would help detect feigned schizophrenic problems. To test this hypothesis, we recorded the eye movements of 83 adult UK volunteers, and tested whether eye movements of healthy volunteers instructed to feign schizophrenia (n = 43) would differ from those of honest controls (n = 40), while engaging in smooth pursuit and pro- and anti-saccade tasks. Additionally, results from our investigation were also compared against previously published data observed in patients with schizophrenia performing similar oculomotor tasks. Data analysis showed that eye movements of experimental participants instructed to feign (a) only partially differed from those of controls and (b) did not closely resemble those from patients with schizophrenia reported in previously published papers. Taken together, these results suggest that examination of eye movements does have the potential to help detecting feigned schizophrenia.
This study was designed to monitor changes in DCE-MRI based parameters Ktrans, ve, τi and Fp in pre-clinical GBM models in response to choline kinase inhibition using a cluster analysis approach. The study demonstrates that region-based clustered pharmacokinetic parameters obtained using DCE-MRI can be used for detecting and assessing tumour heterogeneities which may be useful in assessing therapeutic response.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.